| GTO ID | GTC3467 |
| Trial ID | NCT05887167 |
| Disease | Hematologic Cancer | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Large B-Cell Lymphoma | Multiple Myeloma | Acute Lymphoblastic Leukemia |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies |
| Year | 2023 |
| Country | United States |
| Company sponsor | Joshua Sasine, MD, PhD |
| Other ID(s) | IIT2022-04-Sasine-CAR-T |
| Cohort 1 | |||||||||
|
|||||||||